Spinal muscular atrophy (SMA)

Symptoms of spinal muscular atrophy (SMA)

The symptoms of spinal muscular atrophy (SMA) affect everyone differently, but can include:

These symptoms are most often noticed in babies and toddlers, but they can also start in teenagers and adults.

SMA does not affect intelligence or cause learning disabilities.

Non-urgent advice: See a GP if:

  • you or your child have symptoms of spinal muscular atrophy (SMA)
  • you're worried about your baby or toddler's development
  • you're pregnant or planning a pregnancy and someone in your or your partner's family has SMA

Types of spinal muscular atrophy (SMA)

Spinal muscular atrophy (SMA) is often grouped into types. These are based on the age that symptoms begin and how they affect sitting, standing and walking.

The 4 most common types of SMA
Type When it starts

Type 1

Babies less than 6 months old

Type 2

Babies and toddlers aged 6 to 17 months old

Type 3

Children and teenagers from 18 months to 17 years old

Type 4

Adults 18 years old and over

How spinal muscular atrophy (SMA) affects your life

Although spinal muscular atrophy (SMA) affects everyone differently, some types are considered more severe and can affect how long someone lives.

SMA is usually more severe the earlier symptoms begin. However, the outlook for each type depends on a person's symptoms and how well treatment works.

Information:

Find out more

Causes of spinal muscular atrophy (SMA)

Most types of spinal muscular atrophy (SMA) are caused by an altered gene called SMN1 being passed on to a child by their parents (inherited).

The parents do not usually have SMA themselves, which is known as "carrying" the gene. In most cases, SMA can only be passed on if both parents carry the altered gene.

If both parents carry the altered gene, there's a:

The chances of a child inheriting SMA can be different for some rarer types of SMA. Some rarer types are not passed on at all.

Information:

Find out more

How spinal muscular atrophy (SMA) is diagnosed

If a doctor thinks your child could have spinal muscular atrophy (SMA), a blood test can be used to confirm the diagnosis.

If you're at risk of having a child with SMA, a GP may refer you to a genetic counsellor to discuss the risks and options.

Tests are available before, during and after pregnancy to see if you carry the altered gene or to confirm a diagnosis.

These tests may include:

Treatments for spinal muscular atrophy (SMA)

There is currently no cure for spinal muscular atrophy (SMA), but there are treatments and support available to help people with SMA have the best possible quality of life.

A range of health professionals may be involved in your or your child's care. They'll help to create a care plan and advise you about which treatments are suitable for your specific needs.

Medicines for SMA

The main treatment for SMA is medicines that target the altered genes that cause SMA, including:

It's not always possible to have medicines to help treat SMA. The most suitable treatments will depend on your or your child's age and symptoms. Your care team will be able to discuss the risks and benefits of any possible treatments.

Research is continuing into possible new treatments for SMA.

Treatments and support for living with SMA

Treatment and support is also available for the symptoms of SMA. Every person's needs will be different depending on their symptoms.

Support you or your child might need may include:

People with SMA are also usually advised to have the flu vaccine and pneumococcal vaccine.

Help and support for spinal muscular atrophy (SMA)

If you or your child have spinal muscular atrophy (SMA), health professionals will be there to support you throughout your treatment.

You may also find it helpful to get support from other people with SMA, or parents of children with SMA.

SMA UK

The charity SMA UK provides a range of support and information for people affected by SMA.

Recording information about you and your condition

If you or your child have spinal muscular atrophy (SMA), your care team will pass information on to the National Congenital Anomaly and Rare Disease Registration Service (NCARDRS).

This helps scientists look for better ways to prevent and treat this condition. You can opt out of the register at any time.

Page last reviewed: 23 August 2024
Next review due: 23 August 2027